Exhibit E.docx
DOCX document 23 KB Posted
- Solicitation number
- HT940625QE012
- Issued by
-
Defense Health Agency
About this file
Exhibit E is a detailed pricing and quantity schedule for FDA-approved medications and medical solutions for a Naval Medical Center Portsmouth contract. The document lists 24 specific pharmaceutical products with their National Drug Code (NDC), including precise medication types, concentrations, and maximum annual quantities, such as Glycopyrrolate, Ephedrine Sulfate, Hydromorphone HCl, Ketamine, Midazolam, and various injectable solutions. The document appears to be part of a Firm Fixed Price (FFP) Indefinite Delivery/Indefinite Quantity (IDIQ) supply contract for pre-filled syringes and bags, issued by the Defense Health Agency (DHA) and targeting the Pharmacy Department at Naval Medical Center Portsmouth, with a performance period from October 1, 2029 to September 30, 2030.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Attachment 2- Past Performance Questionnaire.docx | DOCX document | |
| Solicitation - HT940625QE012 0001.pdf | ||
| Exhibit B.docx | DOCX document | |
| Exhibit C.docx | DOCX document | |
| Exhibit A.docx | DOCX document | |
| Solicitation - HT940625QE012.pdf | ||
| Attachment 1 Project Summary Sheet.docx | DOCX document | |
| Attachment 2 Past Performance Questionnaire.docx | DOCX document | |
| Exhibit D.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Exhibit E- POP 01 October 2029 – 30 September 2030 FDA Approved Medications
| National Drug Code |
| Description |
| Max Annual Quantity |
| Unit Price |
| 71266-9015-03 |
| Fagron Glycopyrrolate 0.2mg/mL 0.6mg |
| 300 |
| 71266-9027-01 |
| Ephedrine Sulfate 5mg/mL (25mg/5mL) 5mL Syringe |
| 200 |
| 71266-9110-03 |
| Hydromorphone HCl 0.2mg/mL 30mL |
| 1,000 |
| 71266-9080-02 |
| Ketamine 10mg/mL (API) 5mL Fill in 5mL Syringe |
| 864 |
| 71266-2003-02 |
| Neostigmine Methylsulfate 1mg/mL (API) 5mL |
| 580 |
| 71266-9032-01 |
| PHENYLephrine 0.04mg/mL PF Inj Soln 10mL Syringe |
| 300 |
| 71266-9011-01 |
| PHENYLephrine 0.1mg/mL PF Inj Soln 10mL Syringe |
| 400 |
| 71266-2002-01 |
| Rocuronium Bromide Inj. 10mg/mL (API) 5mL |
| 4,640 |
| 71266-2001-01 |
| SUCCINYLcholine Chl. Inj. USP 100mg/5mL (20mg/mL) |
| 864 |
| 71266-9090-01 |
| Lidocaine HCl 2% 20mg/mL Sol for Inj. PF 5mL |
| 864 |
| 71266-9228-01 |
| Fentanyl Citrate 2mcg/mL Bupivacaine HCl 0.125% 100mL IV Bag |
| 300 |
| 71266-9227-01 |
| Fentanyl Citrate 2mcg/mL Bupivacaine HCl 0.125% 250mL IV Bag |
| 2,000 |
| 71266-9225-01 |
| Fentanyl Citrate 2mcg/mL Bupivacaine HCl 0.0625% 250mL IV Bag |
| 50 |
| 71266-9190-06 |
| Midazolam 1mg/mL 50mL Fill, 50mL syringe API |
| 152 |
| 71266-5030-01 |
| Midazolam 1mg/mL (100mg/100mL) 100mL in 100mL Bag |
| 152 |
| 71266-5030-02 |
| Midazolam 1mg/mL (50mg/50mL) 50mL in 100mL Bag |
| 152 |
| 71266-6290-01 |
| Lidocaine HCl 4% EPINEPHrine Bitartrate 0.18% tetracaine HCl 0.5% Sterile Topical Gel, 5mL syringe, 3mL Fill |
| 152 |
| 71266-6286-03 |
| Lidocaine 4% EPINEPHrine 0.05% tetracaine 0.5% Topical Solution, 5mL syringe, 3mL Fill |
| 152 |
| 71266-5100-01 |
| Fagron Oxytocin 30U Inj Sol 500ml in 500mL Bag |
| 2,752 |
| 71449-018-32 |
| Hydromorphone 1 mg/mL, 30mL in 50mL Syringe |
| 72 |
| 71449-022-32 |
| Morphine Sulfate 5 mg/mL, PF, 30 mL in 50 mL Syringe |
| 864 |
| 71266-9115-01 |
| Hydromorphone HCl 1mg/mL 30mL Fill, 30mL Syr, API |
| 72 |
| 71266-0712-01 |
| 70% Dextrose Injection Solution in 50mL Vial |
| 400 |
| 71266-5026-02 |
| Norepinephrine 16mg 250mL 0.9% NaCl IV Bag S2S |
| 50 |
| 71506-032-58 |
| Norepinephrine 32mg Bag |
| 20 |
| 71266-2010-01 |
| Atropine 0.4mg/1mL Sol for Inj 2mL fill 3mL Syr. |
| 400 |
File details come from the government source that posted it. Updated .